Safety and efficacy of calcitonin gene-related peptide antagonists for cluster headache: a systematic review and meta-analysis

Calcitonin gene-related peptide antagonists provide preventive benefit with acceptable safety in cluster headache. These findings should be interpreted as supportive but less definitive. Larger, long-term, placebo-controlled randomized trials are needed to confirm efficacy and guide clinical use.